Among 29 analysts covering Lloyds Banking Group PLC (LON:LLOY), 19 have Buy rating, 5 Sell and 5 Hold. Therefore 66% are positive. Lloyds Banking Group PLC had 366 analyst reports since July 23, 2015 according to SRatingsIntel. The firm has “Equal Weight” rating by Morgan Stanley given on Wednesday, January 10. The company was maintained on Friday, July 29 by JP Morgan. RBC Capital Markets maintained it with “Outperform” rating and GBX 70 target in Monday, August 15 report. Deutsche Bank maintained the shares of LLOY in report on Monday, March 14 with “Buy” rating. The firm has “Outperform” rating by RBC Capital Markets given on Friday, December 18. The firm has “Hold” rating by Berenberg given on Tuesday, July 26. The stock has “Buy” rating by Deutsche Bank on Thursday, June 16. The rating was maintained by Davy Research on Tuesday, October 25 with “Outperform”. The firm has “Outperform” rating given on Monday, March 19 by Credit Suisse. BNP Paribas maintained the stock with “Neutral” rating in Wednesday, November 11 report. See Lloyds Banking Group plc (LON:LLOY) latest ratings:

Lloyds Banking Group plc provides banking and financial services under the Lloyds Bank, Halifax, Bank of Scotland, and Scottish Widows brands to individual and business clients in the United Kingdom and internationally. The company has market cap of 47.77 billion GBP. The firm operates through four divisions: Retail, Commercial Banking, Consumer Finance, and Insurance. It has a 13.99 P/E ratio. The Retail segment offers a range of financial service products, including current accounts, savings, and mortgages to wealth and small business customers; and distributes insurance products, and a range of long-term savings and investment products.

The stock decreased 0.55% or GBX 0.37 during the last trading session, reaching GBX 67.13. About 109.72M shares traded. Lloyds Banking Group plc (LON:LLOY) has 0.00% since March 19, 2017 and is . It has underperformed by 16.70% the S&P500.

Since October 2, 2017, it had 0 insider buys, and 2 insider sales for $3.09 million activity. $1.42M worth of stock was sold by Foulkes Helena on Friday, February 16. Shares for $1.67M were sold by Moriarty Thomas M on Monday, October 2.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 73 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was downgraded by Wolfe Research to “Hold” on Wednesday, August 16. The stock has “Strong Buy” rating by S&P Research on Monday, November 2. Morgan Stanley downgraded the stock to “Equal-Weight” rating in Monday, June 20 report. The firm has “Buy” rating by Argus Research given on Monday, August 10. On Tuesday, December 26 the stock rating was maintained by Tigress Financial with “Buy”. Robert W. Baird maintained the shares of CVS in report on Wednesday, January 17 with “Hold” rating. The rating was initiated by Robert W. Baird with “Outperform” on Friday, January 22. The stock has “Buy” rating by Needham on Tuesday, January 2. The rating was maintained by Citigroup with “Neutral” on Thursday, August 17. Jefferies maintained CVS Health Corporation (NYSE:CVS) on Friday, September 15 with “Hold” rating.